Rita Nanda
Breast cancer medical oncologist and researcher with expertise in endocrine-resistant disease, targeted agents (PI3K/AKT) and ESR1-mutant therapies, discussing second-line management and ADCs.
Best podcasts with Rita Nanda
Ranked by the Snipd community
Nov 10, 2025 • 1h 58min
Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Dr Rita Nanda, expert in endocrine-resistant HR+ disease and targeted agents. Dr Harold J. Burstein, HER2 specialist with expertise in neoadjuvant and metastatic strategies. Dr Heather McArthur, authority on triple-negative disease and ADCs. Dr Matthew P. Goetz, investigator in HR+ and CDK4/6 research. They discuss genomic assays, sequencing of CDK4/6 and PI3K/AKT agents, ADC selection and toxicities, HER2 strategies, and ctDNA applications.
May 9, 2024 • 2h 13min
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Oncology experts discuss research on metastatic triple-negative breast cancer, including a predictive survival tool and treatment approaches like immunotherapy and antibody drug conjugates. They address challenges in diagnosing and managing complications, exploring immune-related adverse events and CNS progression. The synergy of immune checkpoint inhibitors and ADCs, optimizing treatment sequencing, patient experiences with TDXD therapy, and the role of PARP inhibitors are also highlighted.
